zeneca zd 6169 has been researched along with pyrazines in 1 studies
| Studies (zeneca zd 6169) | Trials (zeneca zd 6169) | Recent Studies (post-2010) (zeneca zd 6169) | Studies (pyrazines) | Trials (pyrazines) | Recent Studies (post-2010) (pyrazines) |
|---|---|---|---|---|---|
| 42 | 0 | 3 | 12,165 | 1,373 | 5,747 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Björkman, JA; Jones, HB; Schofield, J | 1 |
1 other study(ies) available for zeneca zd 6169 and pyrazines
| Article | Year |
|---|---|
Coronary and systemic arterial physiology and immunohistochemical markers related to early coronary arterial lesions in beagle dogs given the potassium channel opener, ZD6169, or the endothelin receptor antagonist, ZD1611.
Topics: Amides; Animals; Arteritis; Benzophenones; Biomarkers; Blood Pressure; Coronary Vessels; Dogs; Electrocardiography; Female; Fibrinogen; Heart; Heart Rate; Immunohistochemistry; Myocardium; Pyrazines; Sulfonamides; von Willebrand Factor | 2013 |